The UK’s Competition and Markets Authority (CMA) has fined several drugmakers for overcharging its health service. The body said the fines, linked to the sale of hydrocortisone tablets, should serve as “warning” to others. On Thursday, the regulator said drug companies would be forced to pay a total of £260 million ($360 million) in fines for engaging in prohibited practices. Firms, including Accord Healthcare, Allergan Plc, Intas Pharmaceuticals, and Waymade Plc, were deemed to have contravened market rules, taking part in activities including paying off their competition, increasing the price of drugs when acting as the sole provide
Hence then, the article about drugmakers fined 260mn for overcharging nhs as price of life saving medicine rose over 10 000 british regulator was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Drugmakers fined £260mn for overcharging NHS as price of life-saving medicine rose over 10,000% – British regulator )